Subscribe
Sign in
Home
Signals Group
Jobs
Companies
Sponsors (2026)
Latest
Top
Discussions
The Current Landscape of Value-Based Kidney Care, Part 2
Business and Financial Performance Across 10 Kidney VBC Models
Dec 16, 2025
•
Tim Fitzpatrick
and
Paul Grill
4
1
What Counts as a Timely Referral for Kidney Transplant?
Why GFR thresholds, access, and real-world practice don’t always line up.
Dec 14, 2025
•
Tim Fitzpatrick
3
1
Finding My Voice in the New York Times
Why patient perspectives matter in the national conversation on organ donation
Dec 7, 2025
5
3
November 2025
Potential Energy: IgAN Milestone, 70k-Patient SGLT2 Data, Creating AI Guardrails, Transplant Trials RFI & Reintroducing KCAPA
Your monthly collection of news, research, and commentary shaping the future of global kidney health
Nov 30, 2025
•
Tim Fitzpatrick
13:25
How do we increase living kidney donation?
Jullie Hoggan shares her path from PKD diagnosis to preemptive transplant, and how lived experience is reshaping support, navigation, and access for…
Nov 23, 2025
•
Tim Fitzpatrick
5
5
3
1:03:57
The Current Landscape of Value-Based Kidney Care, Part 1
A review of publicly reported clinical, operational, and cost outcomes from 7 leading nephrology VBC providers
Nov 20, 2025
•
Tim Fitzpatrick
and
Paul Grill
7
1
How should we deliver kidney care in rural America?
Updated insights on the models, policies, and infrastructure shaping kidney care for 60 million Americans in 86% of the country
Nov 16, 2025
•
Tim Fitzpatrick
2
Aligning Kidney Policy with Patient Needs: A Conversation with Miriam Godwin and Kevin Fowler
The Coalition for Kidney Health’s new roadmap shows how practical, patient-centered policy can make prevention the standard in kidney care
Nov 9, 2025
•
Tim Fitzpatrick
6
2
2
49:36
How To Advance Kidney Health Through Genetic Discovery
Dr. Andy Lazar sheds light on hidden causes of kidney disease, APOL1’s role in disparities, and how genetic testing has transformed his clinical…
Nov 5, 2025
•
Tim Fitzpatrick
1
1
38:09
Predicting Kidney Disease Progression with Biomarkers, Clinical Values, and AI/ML
Renalytix CMO, Michael Donovan, shares lessons learned moving from oncology to nephrology, and why early risk prediction could change how diabetic…
Nov 2, 2025
•
Tim Fitzpatrick
1
41:34
October 2025
Testing Our Limits: AI CKD Screening, Portable PD, VBC Slows eGFR Decline, Immune System Wins Nobel, CRISPR-GPT & More
Your monthly collection of news, research, commentary & discussion shaping the future of global kidney health
Oct 19, 2025
•
Tim Fitzpatrick
3
1
12:10
The State of AI in Kidney Care
From “intellectual lightsabers” to nephrology uptake and legal risks, here's what we learned at the 2025 RPA AI Summit
Oct 14, 2025
•
Tim Fitzpatrick
8
5
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
![Signals From [Space]](https://substackcdn.com/image/fetch/$s_!IXc-!,w_80,h_80,c_fill,f_webp,q_auto:good,fl_progressive:steep,g_auto/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F9f7142a0-6602-495d-ab65-0e4c98cc67d4_450x450.png)
![Signals From [Space]](https://substackcdn.com/image/fetch/$s_!lBsj!,e_trim:10:white/e_trim:10:transparent/h_72,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F0e0f61bc-e3f5-4f03-9c6e-5ca5da1fa095_1848x352.png)
